Nature, Published online: 09 October 2024; doi:10.1038/s41586-024-07943-7
Alterations in the tumour suppressor genes STK11 and/or KEAP1 can identify patients with advanced non-small-cell lung cancer who are likely to benefit from combinations of PD-(L)1 and CTLA4 immune checkpoint inhibitors added to chemotherapy.
Source link
Anthropic, a San Francisco startup often cast as an independent player in the AI race,…
I had stints where I didn’t drink, but that dry January felt different. I tucked…
How do the top 1% of Americans invest their money, and how do your investments…
Saturn now has a total of 274 moonsNASA/JPL/Space Science Institute A further 128 moons have…
Katamari Damacy Rolling LIVE is an Apple Arcade exclusive and sees you rolling up objects…
President Donald Trump on Tuesday backed off a 50% tariff on imports of Canadian steel…